Hunter Land
Company: Biopharmaceutical Research Co.
Job title: Vice President, Research and Development
Seminars:
Panel Discussion: Drug-to-Drug Interactions in Combination with CBD 5:00 pm
day: Day One
Evidence to Support CBD in Diseases of High Mortality: Rationale for Polypharmacy 4:30 pm
In depth discussion of late breaking data comparing CBD isolate to cannflavins and cannabinoids used in combination in the Tau model of neurodegenerative disease Rationale and evidence for the long-term use of cannabinoids use in diseases with high mortality Analyzing the nuance of cannabinoid rational polypharmacy, "entourage vs non-tourage"Read more
day: Day One